GlaxoSmithKline (GSK) Reports Q3 Adj-EPS of 28.2P, Sales £6.81B
Tweet Send to a Friend
GlaxoSmithKline (NYSE: GSK) reports ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE